United States · 
Who invested in Mozart Therapeutics?
Mozart Therapeutics's investors include ARCH Venture Partners, Sofinnova Partners, Eli Lilly, Alexandria Venture Investments and AbbVie.
United States · Series A startup
Who invested in Mozart Therapeutics
One round we have observed, with the 5 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$25Mraised across 1 round since 2023, from 1 source
- Latest round
- Series A, $25MJun 2023
- Investors
- 5
The rounds
- Jun 2023Series A$25M
Source recorded
Everyone who backed them
Alexandria Venture InvestmentsVC firm1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Mozart Therapeutics
How much has Mozart Therapeutics raised?
Mozart Therapeutics has raised $25M across 1 round since 2023.
When did Mozart Therapeutics last raise?
Mozart Therapeutics's most recent round was a Series A of $25M in Jun 2023.
What was Mozart Therapeutics's biggest round?
Its most recent round, $25M in Jun 2023, is also its largest on record.
Who backed Mozart Therapeutics first?
Mozart Therapeutics's first round on record, in Jun 2023, was backed by ARCH Venture Partners, Sofinnova Partners and Eli Lilly and 2 others.
What stage is Mozart Therapeutics at?
Mozart Therapeutics's latest named round is a Series A, in Jun 2023.
Where is Mozart Therapeutics based?
Mozart Therapeutics is based in the United States.
Companies like Mozart Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.